Markets:

Overview

News

Currencies

International

Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

17.22 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Nvidia’s $100B Bet in OpenAI Pushes Wall Street to Fresh Records ↗

September 23, 2025

Tech did the heavy lifting as Nvidia and Apple dragged indexes over the finish line; gold hit yet another all-time high while oil sagged. The Fed chorus grew louder and more discordant.

Via Chartmill

Topics Economy

Johnson & Johnson Stock Weathers Trump’s Tylenol Attacks Better Than Kenvue Amid Dipping Retail Confidence — What’s Holding Losses in Check? ↗

September 23, 2025

Guggenheim’s upgrade and new data on J&J’s experimental depression drug helped steady sentiment, even as investors weighed political scrutiny and ongoing litigation risks.

Via Stocktwits

Topics Government

Nvidia, Kenvue, Rivian, MicroCloud Hologram And Opendoor: Why These 5 Stocks Are On Investors' Radars Today ↗

September 22, 2025

U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average edging up 0.14% to 46,381.54.

Via Benzinga

Topics Stocks

Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullish ↗

September 22, 2025

Via Stocktwits

Topics Government

Kenvue Shares Drop Ahead Of Trump’s ‘Biggest Announcement’ On Autism: Reports Say Administration To Link Tylenol With Risk Of Disease ↗

September 22, 2025

Via Stocktwits

Topics Government

Tylenol Maker Kenvue Met With RFK Jr. In A Bid To Keep OTC Painkiller Off Autism List: Report ↗

September 12, 2025

Via Stocktwits

What 8 Analyst Ratings Have To Say About Kenvue ↗

September 08, 2025

Via Benzinga

Which S&P500 stocks are moving on Monday? ↗

September 22, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday.

Via Chartmill

Curious about the most active S&P500 stocks in today's session? ↗

September 22, 2025

Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Monday. Discover the stocks that are generating the highest...

Via Chartmill

Stocks Extend Records, Gold Soars To $3,740: What's Moving Markets Monday? ↗

September 22, 2025

Wall Street is on track for its third straight day of gains, with major large-cap indices extending records as investors remain optimistic about corporate earnings and upcoming rate cuts.

Via Benzinga

Kenvue Stock Is Sliding Today: What's Fueling The Sell-Off? ↗

September 22, 2025

Shares of Kenvue Inc (NASDAQ: KVUE) are down Monday in anticipation of a negative Trump administration announcement about one of its products.

Via Benzinga

Topics Government

Top S&P500 movers in Monday's session ↗

September 22, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Growth Titans: Eli Lilly's Weight-Loss Surge vs. Johnson & Johnson's Diversified Might

September 22, 2025

The pharmaceutical landscape is currently a tale of two giants employing vastly different, yet highly successful, growth strategies. Eli Lilly and Company (NYSE: LLY) has placed an extraordinary bet on...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Which S&P500 stocks are gapping on Monday? ↗

September 22, 2025

Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

What's going on in today's pre-market session: S&P500 movers ↗

September 22, 2025

Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Trump Administration To Unveil Tylenol-Autism Review, Tout This Drug As Potential Treatment: Report ↗

September 22, 2025

Trump administration to announce concerns about Tylenol use in pregnancy and potential treatment for autism, in line with President's priority.

Via Benzinga

Topics Government

Kenvue, J&J Retail Traders Cautious As US Health Officials Reportedly Plan To Announce Tylenol Links To Autism ↗

September 22, 2025

Tylenol is one of the most common medicines for reducing pain and fever, and a major product for Kenvue.

Via Stocktwits

Topics Government

Johnson & Johnson Confronts the End of its Talc Legacy with Multi-Billion Dollar Settlements

September 19, 2025

Johnson & Johnson (NYSE: JNJ) is navigating a critical juncture in its protracted legal battle over talc-based baby powder. The healthcare behemoth has announced a tentative $700 million settlement...

Via MarketMinute

Topics Bankruptcy Death Lawsuit

Jim Cramer's Warning On This Oil Stock: 'You Don't Want To Be In It' ↗

September 19, 2025

Jim Cramer discussed companies such as Western Union, Johnson Controls, MNTN, Nordic American Tankers, Occidental Petroleum, and Kenvue on CNBC's Mad Money Lightning Round.

Via Benzinga

Explore the top gainers and losers within the S&P500 index in today's session. ↗

September 15, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Monday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

September 15, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Kenvue Pushes To Defend Pain Killer Tylenol Against Autism Claims Ahead Of Government Report ↗

September 12, 2025

Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and autism.

Via Benzinga

Which S&P500 stocks are the most active on Monday? ↗

September 08, 2025

Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session.

Via Chartmill

Kenvue Seen As Attractive Buy By BofA After Stock Dip Following Report On Tylenol Autism Link ↗

September 08, 2025

Evercore said that the recent selloff in shares "might be overdone" when considering the lack of a proven causal link between Tylenol's active ingredient and neurodevelopmental disorders.

Via Stocktwits

Market Monitor Trends and Breadth September 08 BMO - Wall Street Stumbles as Weak Jobs Report Stirs Recession Fears ↗

September 08, 2025

A softer-than-expected U.S. labor market spooked investors on Friday, dragging major indices lower despite initial optimism over potential Fed rate cuts. Gold surged to record highs as traders sought...

Via Chartmill

Topics Economy

Top S&P500 movers in Friday's session ↗

September 05, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

RFK Jr. To Link Tylenol Use To Autism: Report ↗

September 05, 2025

RFK Jr. is preparing to release a report suggesting that the use of Tylenol during pregnancy may be tied to a higher risk of autism.

Via Benzinga

Kenvue Stock Hits One-Year Low After Report Says HHS Will Link Tylenol Use in Pregnancy to Autism Risk ↗

September 05, 2025

According to a report by The Wall Street Journal, the Department of Health and Human Services is likely to release its findings later this month.

Via Stocktwits

Topics Economy

Which S&P500 stocks are the most active on Friday? ↗

September 05, 2025

Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.

Via Chartmill

JNJ Stock Surge Signals Confidence in New Growth Path ↗

August 25, 2025

Johnson & Johnson's strategic shift to a focused pharma and medtech model is fueling growth through a powerful drug pipeline and key acquisitions.

Via MarketBeat

Topics Lawsuit

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.